Group | Timing | N | Seroprotected | GMT (mIU/mL) | |||||
---|---|---|---|---|---|---|---|---|---|
 |  |  | n | % | 95% CI |  | Value | 95% CI |  |
RTS,S/AS02D | SCREENING | 115 | 44 | 38.3 | 29.4 | 47.8 | 14.5 | 10.9 | 19.2 |
 | Post Dose 2 (Month 2) | 148 | 140 | 94.6 | 89.6 | 97.6 | 110.9 | 89.1 | 138.1 |
 | Post Dose 3 (Month 3) | 140 | 140 | 100 | 97.4 | 100 | 667.3 | 532.9 | 835.7 |
 | Post Dose 3 (Month 20) | 131 | 131 | 100 | 97.2 | 100 | 1520.6 | 1206.8 | 1915.8 |
Hepatitis B | SCREENING | 131 | 45 | 34.4 | 26.3 | 43.1 | 13.3 | 10.0 | 17.6 |
vaccine | Post Dose 2 (Month 2) | 147 | 82 | 55.8 | 47.4 | 64.0 | 17.1 | 13.6 | 21.4 |
 | Post Dose 3 (Month 3) | 141 | 133 | 94.3 | 89.1 | 97.5 | 113.8 | 91.3 | 141.8 |
 | Post Dose 3 (Month 20) | 132 | 129 | 97.7 | 93.5 | 99.5 | 184.3 | 144.4 | 235.4 |